Cis-platinum: a new anticancer agent.
D000818:Animals; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004285:Dogs; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity; D005260:Female; D006207:Half-Life; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008274:Magnesium / Q000097:blood; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D008274:Magnesium; D002945:Cisplatin